Literature Review of Ascorbic Acid, Cranberry, and D-mannose for Urinary Tract Infection Prophylaxis in Older People.

Q2 Medicine Senior Care Pharmacist Pub Date : 2023-08-01 DOI:10.4140/TCP.n.2023.315
Grace Song, Mira Koro, Vivian Leung, Gabriel Loh
{"title":"Literature Review of Ascorbic Acid, Cranberry, and D-mannose for Urinary Tract Infection Prophylaxis in Older People.","authors":"Grace Song,&nbsp;Mira Koro,&nbsp;Vivian Leung,&nbsp;Gabriel Loh","doi":"10.4140/TCP.n.2023.315","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b> Urinary tract infections (UTIs) are the most prevalent infections in older patients with the potential for morbidity and mortality. Antibiotics are not generally recommended for UTI prophylaxis in this population. There is interest among the public and health providers to try over-the-counter products, such as cranberry, D-mannose, and vitamin C. The objective of this analysis was to review the literature for the efficacy and tolerability of these supplements in older individuals. <b>Methods</b> A literature review was conducted on PubMed using the search terms urinary tract infection or UTI, prevention/prophylaxis, cranberry, D-mannose, vitamin C/ascorbic acid. Few studies were conducted among older people; therefore, the authors included studies of all adults who had recurrent UTIs or were at increased risk of UTIs. Level (quality) of evidence were determined using the ACC/AHA Clinical Practice Guideline Recommendation Classification System. <b>Results</b> A total of 24 studies were included. This review captured all studies in previous reviews as well as recent publications. The authors determined that there were limited data for D-mannose and vitamin C, and randomized data for cranberry as defined by the classification system. <b>Conclusions</b> The three supplements reviewed appear not to be strongly supported by clinical data. For those who are interested in trying these products despite the lack of robust evidence for clinical efficacy, it may be helpful to know that the studies included in this review did not identify any clinically important signs of harm, to the extent that safety data were documented and reported.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"38 8","pages":"315-328"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2023.315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background Urinary tract infections (UTIs) are the most prevalent infections in older patients with the potential for morbidity and mortality. Antibiotics are not generally recommended for UTI prophylaxis in this population. There is interest among the public and health providers to try over-the-counter products, such as cranberry, D-mannose, and vitamin C. The objective of this analysis was to review the literature for the efficacy and tolerability of these supplements in older individuals. Methods A literature review was conducted on PubMed using the search terms urinary tract infection or UTI, prevention/prophylaxis, cranberry, D-mannose, vitamin C/ascorbic acid. Few studies were conducted among older people; therefore, the authors included studies of all adults who had recurrent UTIs or were at increased risk of UTIs. Level (quality) of evidence were determined using the ACC/AHA Clinical Practice Guideline Recommendation Classification System. Results A total of 24 studies were included. This review captured all studies in previous reviews as well as recent publications. The authors determined that there were limited data for D-mannose and vitamin C, and randomized data for cranberry as defined by the classification system. Conclusions The three supplements reviewed appear not to be strongly supported by clinical data. For those who are interested in trying these products despite the lack of robust evidence for clinical efficacy, it may be helpful to know that the studies included in this review did not identify any clinically important signs of harm, to the extent that safety data were documented and reported.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗坏血酸、蔓越莓和d -甘露糖预防老年人尿路感染的文献综述。
尿路感染(uti)是老年患者中最常见的感染,具有潜在的发病率和死亡率。在这一人群中,一般不建议使用抗生素预防尿路感染。公众和医疗服务提供者对尝试蔓越莓、d -甘露糖和维生素c等非处方产品很感兴趣。本分析的目的是回顾有关这些补充剂对老年人的疗效和耐受性的文献。方法以尿路感染或UTI、预防/预防、蔓越莓、d -甘露糖、维生素C/抗坏血酸为检索词,在PubMed上进行文献检索。在老年人中进行的研究很少;因此,作者纳入了所有患有复发性尿路感染或尿路感染风险增加的成年人的研究。采用ACC/AHA临床实践指南推荐分类系统确定证据水平(质量)。结果共纳入24项研究。本综述收录了以前综述中的所有研究以及最近发表的文献。作者确定d -甘露糖和维生素C的数据有限,并且根据分类系统定义的蔓越莓随机数据。结论:这三种补充剂似乎没有临床数据的有力支持。对于那些尽管缺乏临床疗效的有力证据但仍有兴趣尝试这些产品的人来说,了解本综述中包括的研究没有发现任何临床重要的危害迹象,在一定程度上记录和报告了安全性数据,可能会有所帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Senior Care Pharmacist
Senior Care Pharmacist PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
160
期刊最新文献
Co-designing Medication Optimization Patient-Centered Outcomes Research With Older People and Caregivers as Research Partners. Heart Failure Part 3: Diuretic Management in Older People. How Should the Scope of Pharmacy Practice Be Decided? Marsha Meyer PRESIDENT 2024-2025. Notes on the Consultant Pharmacist Practice Model: At Home and Abroad.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1